Diagnosis & treatment

Imagine a treatment that boosts your own immune response to fight lung cancer with precision, causing virtually no side effects while you maintain your daily routine. Dendritic cell therapy offers this possibility to patients at any cancer stage, showing effectiveness rates of 50-65% across various cancer types. With lung cancer affecting 226,650 new...

Dendritic cell prostate cancer treatment represents a groundbreaking immunotherapy approach, recognized by the 2011 Nobel Prize in Physiology or Medicine, awarded to Ralph Steinman. This innovative method can be prescribed to men of all ages and at any stage of prostate cancer, serving as an effective addition to standard treatment....

Standard therapy for glioblastoma includes surgical removal of the tumor in combination with chemotherapy or radiation therapy. With standard treatment of glioblastoma, the average life expectancy after diagnosis is 15-17 months, and the 5-year survival rate does not exceed 5-10%. Supplementing the standard protocol with the dendritic cell...

Cervical cancer affects approximately 660,000 women worldwide each year, making it the fourth most common cancer among women globally. While early detection typically offers excellent cure rates, advanced cases require innovative treatment approaches. Dendritic cell therapy represents a promising personalized immunotherapy...

With diabetes affecting 589 million adults worldwide – representing 1 in 9 adults – and projections showing this could reach 853 million by 2050, innovative treatment approaches are increasingly vital. Stem cell treatment for diabetes is a method of treating diabetes mellitus by injecting stem cells, own or donor ones. The method is...

Stomach cancer is a malignant pathology that ranks among the ten most common cancers in the world. More than 1 million new cases are diagnosed every year. The disease most often develops in males between 35 to 40 years old. Screening and awareness of potential causes are crucial for improving the prognosis, as gastric cancer diagnosed....

Liver cancer typically strikes between the ages of 50 and 65, ranking as the 5th most common cancer in men and 9th in women. The sobering reality is that three-quarters of cases go undetected until the disease has already spread – a stage 4 diagnosis that traditionally meant a prognosis measured in months, not years. But here's what's changing...

The liver is the body's laboratory, filtering blood and performing hundreds of vital functions. Unfortunately, this makes it vulnerable to cancer cells that travel through the bloodstream and settle there, forming secondary liver cancer called metastases. According to large-scale studies, colorectal cancer accounts for 21.4% of liver metastases...